Table 4 Socioeconomic impact and catastrophic costs in patients diagnosed through ACF and PCF at individual treatment periods
Variables | Pre-treatment, N (%) | ORd (95 % CI) | Intensive phase, N (%) | ORd (95 % CI) | Continuation phase, N (%) | ORd (95 % CI) | End of treatment, N (%) | ORd (95 % CI) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ACF (N = 52) | PCF (N = 46) | ACF (N = 52) | PCF (N = 46) | ACF (N = 52) | PCF (N = 46) | ACF (N = 52) | PCF (N = 46) | |||||
Catastrophic costsa | 8 (15) | 13 (30) | 0.43 (0.16–1.17) | 8 (22) | 17 (46) | 0.32 (0.12–0.90)* | 11 (22) | 12 (27) | 0.76 (0.30–1.93) | 10 (20) | 10 (22) | 0.86 (0.32–2.29) |
Unemployed | 5 (10) | 8 (17) | 0.51 (0.15–1.67) | 15 (29) | 21 (46) | 0.48 (0.21–1.11) | 10 (19) | 10 (22) | 0.86 (0.32–2.29) | 7 (13) | 9 (20) | 0.64 (0.22–1.88) |
Poverty headcountb | 11 (21) | 8 (17) | 1.27 (0.46–3.51) | 22 (42) | 19 (41) | 1.04 (0.47–2.33) | 12 (23) | 10 (22) | 1.08 (0.42–2.80) | 11 (21) | 9 (20) | 1.10 (0.41–2.96) |
Social exclusion | NA | NA | NA | 21 (66) | 11 (34) | 2.16 (0.90–5.17) | 19 (41) | 27 (59) | 0.41 (0.18–0.91)* | 19 (45) | 23 (55) | 0.58 (0.26–1.29) |
Loss of employment | NA | NA | NA | 15 (29) | 18 (39) | 0.63 (0.27–1.47) | 12 (23) | 16 (35) | 0.56 (0.23–1.36) | 8 (15) | 11 (24) | 0.58 (0.21–1.59) |
Financial impactc | NA | NA | NA | 29 (56) | 18 (39) | 1.96 (0.87–4.39) | 27 (52) | 20 (43) | 1.40 (0.63–3.11) | 19 (37) | 19 (41) | 0.82 (0.36–1.84) |
Coping strategies | NA | NA | NA | 14 (27) | 7 (15) | 2.05 (0.75–5.64) | 20 (38) | 5 (11) | 5.12 (1.73–15.14)* | 15 (29) | 11 (24) | 1.29 (0.51–3.18) |